Caplin Point Laboratories Ltd

Caplin Point
Providing remedies
BRINGING SMILES to people
We Choose To Be
DIFFERENT
We always took
the road less travelled and
that has made ALL THE DIFFERENCE

INVESTOR

Postal Ballot Notice

Annual Reports

2019-2020
- Annual Report

2018 -2019
- Annual Report
- Attendence Slip
- E - Voting Instruction
- Notice

2017 -18
- Annual Report
- Attendence Slip
- E- voting instruction
- Notice

2016-17
- Annual Report
- Notice
- Addendum to Annual Report 2016-17

2015-16
- Annual Report
- Attendance Slip

2013-14
- Annual Report
- Attendance Slip

2012-13

2014-15

2014-15

2011-12

2010-11

2009-10

2008-09

Terms and Conditions for Appointment of Independent Director

Terms and Conditions for Appointment of Independent Director.

Financial Results

2020-21
- March 2021
- June 2020
- December 2020
- September,2020

2019 - 20
- Mar 2020
- December 2019
- September 2019
- June 2019

2018-19
- December 2018
- March 2019
- September 2018
- June 2018

2017-18
- March -2018
- September 2017
- June 2017
- December 2017

2016-17
- March 2017
- December 2016
- September 2016
- June 2016

2015-16
- Mar 2016
- Dec 2015
- Sep 2015

2014-15
- June 2015
- Mar 2015
- Dec 2014
- Sep 2014

2013-14
- June 2014
- Mar 2014
- Dec 2013
- Sep 2013

2012-13

2011-12

2010-11

2009-10

2008-09

Company Polices & Code of Conduct

FAIR DISCLOSURE OF UNPUBLISHED PRICE SENSITIVE INFORMATION

RELATED PARTY TRANSACTION POLICY.

Dividend Distribution Policy

CRITERIA FOR MAKING PAYMENT TO NON-EXECUTIVE DIRECTOR

POLICY ON MATERIAL SUBSIDIARY.

POLICY ON PRESERVATION OF RECORDS/ ARCHIVAL POLICY.

POLICY FOR DETERMINATION OF MATERIALITY OF EVENTS.

FAMILIARIZATION PROGRAMME FOR INDEPENDENT DIRECTORS.

NOMINATION AND REMUNERATION POLICY.

CODE OF CONDUCT.

WHISTLE BLOWER POLICY(VIGIL MECHANISM).

CORPORATE SOCIAL RESPONSIBILITY(CSR)POLICY.

RELATED PARTY TRANSACTION POLICY. 2016

Stock Exchange Intimation

29.10.2020 - Board Meeting Intimation

30.10.2020 - Conference Call

30.09.2020 - Trading Window Closure

29.09.2020 - Outcome of the AGM

14.09.2020- Revised Book Closure Dates

12.09.2020- Notice of Book Closure

10.08.2020-Outcome of the Board Meeting

03.08.2020- Conference Call

03.08.2020- Board Meeting Intimation

07.07.2020 - Press Release

18.06.2020-Outcome of Board Meeting

10.06.2020 - Board Meeting Intimation

10.06.2020 -Conference Call

12.06.2020- Press Release

13.04.2020- Press Release

31.03.2020- Trading Window Closure

26.03.2020- Press Release

04.03.2020-Outcome of the Board Meeting

28.02.2020-Board Meeting Intimation

05.02.2020- Outcome of the Board Meeting

27.01.2020 - Board Meeting Intimation

05.12.2019 - Demise of a Director

03.12.2019- Press Release

30.10.2019 - Re-appointment of Independent Director

30.10.2019 - Un-audited financial results and Press release

21.10.2019 - Board Meeting Intimation

30.09.2019 - Intimation of Trading window closure

13.09.2019 - Summary of proceedings of the 28th Annual General Meeting

12.08.2019 - Un-audited financial results and Press release

02.08.2019 - Board Meeting Intimation

25.07.2019 - Press Release

18.07.2019 - Press Release

29.06.2019 - Closure of Trading Window

20.06.2019 - Disclosure of Related Party Transactions pursuant to Reg 23(9) of SEBI (LODR) Regulations, 2015

17.06.2019 - Press Release

31.05.2019 - Allotment of Shares under ESOP

22.05.2019 - Audited Financial Results and Press Release

13.05.2019 - Press Release

11.04.2019 Resignation of Dr Philip Ashok Karunakaran,Whole-time Director

08.04.2019 - Press Release

05.04.2019-Closure of Trading Window

22.03.2019 - Press Release

10.02.2019 - Allotment of Shares under ESOP

11.02.2019 Unaudited financial results

31.01.2019 - Earnings Conference Call

24.01.2019 - Board Meeting Intimation

18.01.2019 - Outcome of the Board Meeting

18.01.2019 - Execution of Business Transfer Agreement

11.01.2019 -Intimation for Board Meeting

11.01.2019- Outcome of the Board Meeting

02.01.2019-Board Meeting Intimation

17.12.2018 - Incorporation of Wholly Owned Subsidiary Company

30.11.2018 - Notice of Postal Ballot

19.11.2018 - Outcome of the Board Meeting

02.11.2018 - Outcome of the Board Meeting

09.10.2018 - Board Meeting intimation

29.09.2018 - Summary of Proceedings of the 27th Annual General Meeting

14.09.2018 - Joint Venture Agreement

07.08.2018 - SUCCESSFUL US FDA INSPECTION AT STERILE INJECTABLE SITE (CP IV)

04.08.2018 - Intimation of book closure date

04.08.2018 - Notice of the AGM

12.07.2018 - Board Meeting Intimation

06.06.2018 - Press Release

01.06.2018- Investor Information

28.05.2018- Audited Financial Results & Dividend and press release for 31.03.2018

08.05.2018 - Re-appointment of Mr R Viswanathan as an Independent Director.

02.05.2018- Board meeting intimation

29.03.2018 - Cessation of Director

12.03.2018 - Outcome of the Board Meeting

01.03.2018- Board Meeting Intimation

15.02.2018 - Allotment of shares under ESOP

07.02.2018 - Re-appointment of director

07.02.2018 - Grant of options

10.01.2018- Board Meeting Intimation

09.11.2017- Un-audited financial results and press release

09.11.2017- outcome of the Board Meeting

16.10.2017- Board Meeting Intimation

22.09.2017 -Proceedings of AGM

21.09.2017 -Outcome of the AGM

20.09.2017- Press Release.

28.08.2017 - 26th Annual General Meeting Notice

28.08.2017 - Intimation of Book closure Date

07.08.2017 - Out come of the Board Meeting

20.07.2017-Change in RTA

10.05.2017 - Press Release

10.05.2017- Dividend Recommendation

08.05.2017 - Press Release

17.04.2017 - Board Meeting Intimation

05.04.2017 - Grant of Stock Options

10.02.2017 - Allotment of Equity shares

12.01.2017 - Board Meeting Intimation

11.11.2016 - Out Come of Conference Call

09.11.2016 - Appointment of Mr D Sathyanarayanan as an Additional Director

29.10.2016 - US FDA

18.10.2016 - Board Meeting Intimation

17.10.2016 - New ISIN

05.10.2016 -Record date

14.09.2016 - Voting Results - AGM, September 2016

14.09.2016 - Proceedings of 25th Annual General Meeting - September 2016

12.09.2016 - Outcome of AGM - September 2016

25.08.2016 - Compliance under Regulation 30 of SEBI (LODR), 2015.

22.08.2016 - Book Closure

05.08.2016 - sub division of shares.

05.08.2016 – Press Release.

28.07.2016 - Updates for the ensuing Board Meeting.

21.07.2016 - Sub Division of Equity Shares.

27.05.2016 – Press Release.

27.05.2016 – Board Recommends Final Dividend.

17.05.2016 - Board Meeting Intimation.

02.05.2016 - Change in Designation of Mr D P Mishra

18.03.2016 - AUTHORISATION TO KMP'S FOR DETERMINING MATERIALITY OF EVENTS.

Shareholding Pattern

March 31, 2021

December 31,2020

December 31,2020

September 30,2020

June 30 2020

March 31, 2020

December 31,2019

September 30, 2019

June 30, 2019

March 31,2019

December 31,2018

June 30,2018

March 31,2018

December 31, 2017

September 30,2017

March 31,2017

December 31, 2016

September 30,2016

June 30, 2016

March 31, 2016

December 31, 2015

September 30, 2015

June 30, 2015

Mar 31, 2015

Dec 31, 2014

Sep 30, 2014

June 30, 2014

March 31, 2014

December 31, 2013

September 30, 2013

June 30, 2013

March 31, 2013

December 31, 2012

September 30, 2012

June 30,2012

March 31, 2012

December 31, 2011

September 30, 2011

June 30, 2011

Unpaid Dividend Account

2018 - 19

2017 -18

2016-17

2015-16 Final Dividend

2015-16 Interim Dividend

2014-15

2013-14

2012-13

2011-12

Forms

E-Mail Registration Form

Securities Transfer Form SH 4

Form SH 13-Nomination Form

Voting Results

Annual General Meeting-2020

Annual General Meeting 2019

Postal Ballot Result

Annual General Meeting 2018

Annual General Meeting - 2017

Annual General Meeting - 2016

Annual General Meeting-2015

Annual General Meeting-2014

Composition of Committees

Composition of commitee

Transcript of Investors Call

04.02.2021-Q3FY21 Earnings Conference Call Transcript

06.11.2020-Q2FY21 Earnings Conference Call Transcript

11.08.2020 -Q1FY21 Earning Conference Call Transcript

18.06.2020 -Q4 FY Earnings Conference Call Transcript

30.10.2019 - Q2 FY 20 Earnings Conference Call Transcript

Investor Presentation

December 2020

September,2020

June, 2020

March,2020

December,2019

February, 2019

Shares Transferred to Investor Education and Protection Fund

2019

2018

Disclosure of Related Party Transactions pursuant to Reg 23(9) of SEBI (LODR) Regulations, 2015

September 30,2020

March 31,2020

September 30,2019

March 31, 2019

Shares which are liable to be transferred to IEPF -2019

2019

Shares which are liable to be transferred to IEPF -2020

2020

Press Release

Press Release for Un-Audited Financial Results for Quarter and Nine months ended December 31, 2020

22.01.2021-CAPLIN STERILES GETS USFDA APPROVAL FOR ARGATROBAN INJECTION

18.01.2020-CAPLIN STERILES ENTERS INTO A STRATEGIC PARTNERSHIP WITH JAMP PHARMA GROUP FOR CANADA

24.12.2020-CAPLIN STERILES GETS USFDA APPROVAL FOR ETOMIDATE INJECTION USP

05.10.2020- Press Release for Un-audited Financial Results for the quarter/half year ended September 30,2020

10.08.2020- Press Release for Un-audited Financial Results for the quarter ended June 30,2020

Subsidiary Accounts

Subsidiary Accounts 2019 – 2020
- Caplin Steriles Limited
- Caplin Point (S) Pte. Ltd.
- Argus Salud Pharma
- Caplin Point Far East Limited, Hong Kong
- Caplin Point Colombia SAS, Colombia

Subsidiary Accounts 2018 - 2019
- Caplin Steriles Limited
- Argus Salud Pharma
- Caplin Point Far East Limited, Hong Kong
- Caplin Point Colombia SAS, Colombia

Subsidiary Accounts 2017 – 2018
- Caplin Point Colombia SAS
- Argus Salud Pharma
- Caplin Point Far East Limited, Hong Kong

Corporate Governance

March 2021

For Any Queries And Complaint Please
Email to: investor@caplinpoint.net

CONTACT US

Registered Office

Caplin Point Laboratories Ltd.
3rd Floor, Ashvich Towers,
No 3, Developed Plots Industrial Estate,
Perungudi, Chennai 600096
Tamil Nadu, India

USEFUL LINKS

LIFE AT CAPLIN POINT

Be Part of Caplin

© Caplin Point Laboratories Ltd. All Rights Reserved.

Design by Global Trendz